JAMDA
Volume 8, Issue 3, Supplement 2 , Pages e67-e73 , March 2007

To Treat or Not To Treat, That Is the Question: Proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-Term Care Institutions, Saint-Hyacinthe, Quebec, November 5, 2004

  • Gustavo Duque, MD, PhD

      Affiliations

    • Division of Geriatric Medicine, McGill University, Montreal, Quebec, Canada
    • Centre d’hébergement de Longue Durée, Lachine, Quebec, Canada
    • Corresponding Author InformationAddress correspondence to Gustavo Duque, MD, PhD, Division of Geriatric Medicine, McGill University-Jewish General Hospital, 3755, Cote Sainte Catherine, Montreal, QC, Canada, H3T 1E2.
    • ,
  • Louise Mallet, PharmD

      Affiliations

    • Division of Geriatric Medicine, McGill University, Montreal, Quebec, Canada
    • Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    • ,
  • Ayanna Roberts

      Affiliations

    • Division of Geriatric Medicine, McGill University, Montreal, Quebec, Canada
    • ,
  • Serge Gingrass, MD

      Affiliations

    • Centre for Bone and Periodontal Research, McGill University, Montreal, Quebec, Canada
    • ,
  • Richard Kremer, MD, PhD

      Affiliations

    • Centre for Bone and Periodontal Research, McGill University, Montreal, Quebec, Canada
    • ,
  • Louis-Georges Sainte-Marie, MD

      Affiliations

    • Division of Endocrinology, University of Montreal, Montreal, Quebec, Canada
    • ,
  • Douglas P. Kiel, MD

      Affiliations

    • Institute for Aging Research, Hebrew SeniorLife and Havard Medical School, Boston, MA.

References 

  1. Medina-Walpole A, Katz PR. Nursing home care. In:  Hazzard WR,  Blass JP,  Halter JB,  Ouslander JG editor. Principles of Geriatric Medicine and Gerontology. 5th ed.. New York: McGraw Hill; 2003;
  2. Ooms ME, Vlasman P, Lips P, et al. The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int. 1994;4:6–10
  3. Girman CJ, Chandler JM, Zimmerman SI, et al. Prediction of fracture in nursing home residents. J Am Geriatr Soc. 2002;50:1341–1347
  4. Wallace RB. Bone health in nursing home residents. Jama. 2000;284:1018–1019
  5. Chandler JM, Zimmerman SI, Girman CJ, et al. Low bone mineral density and risk of fracture in white female nursing home residents. Jama. 2000;284:972–977
  6. Greenspan SL, Myers ER, Kiel DP, et al. Fall direction, bone mineral density, and function: Risk factors for hip fracture in frail nursing home elderly. Am J Med. 1998;104:539–545
  7. Gloth FM. Osteoporosis in long term care (Part 1 of 2: Recognizing bone and beyond). Director. 2004;12:175–176179–180
  8. Broe KE, Hannan MT, Kiely DK, et al. Predicting fractures using bone mineral density: a prospective study of long-term care residents. Osteoporos Int. 2000;11:765–771
  9. Zimmerman SI, Girman CJ, Buie VC, et al. The prevalence of osteoporosis in nursing home residents. Osteoporos Int. 1999;9:151–157
  10. Zimmerman S, Chandler JM, Hawkes W, et al. Effect of fracture on the health care use of nursing home residents. Arch Intern Med. 2002;162:1502–1508
  11. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24–35
  12. Hajjar RR, Kamel HK. Osteoporosis for the home care physician (Part 1: Etiology and current diagnostic strategies). J Am Med Dir Assoc. 2004;5:192–196
  13. Schousboe JT, Ensrud KE, Nyman JA, et al. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc. 2005;53:1697–1704
  14. Gupta G, Aronow WS. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents. J Am Med Dir Assoc. 2003;4:200–202
  15. Elliott ME, Binkley NC, Carnes M, et al. Fracture risks for women in long-term care: High prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy. 2003;23:702–710
  16. Brown JP, Josse RG Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Cmaj. 2002;167:1–34
  17. Saliba D, Solomon D, Rubenstein L, et al. Quality indicators for the management of medical conditions in nursing home residents. J Am Med Dir Assoc. 2004;5:297–309
  18. Kamel HK. Underutilization of calcium and vitamin D supplements in an academic long-term care facility. J Am Med Dir Assoc. 2004;5:98–100
  19. Jachna CM, Shireman TI, Whittle J, et al. Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers. J Am Geriatr Soc. 2005;53:1275–1281
  20. Bergman H, Montambault J. Services d’hébergement. In:  Arcand M,  Hébert R editor. Précis pratique de gériatrie. 2nd ed.. St-Hyacinthe, Quebec: Maloine, Fédération des médecins omnipraticiens du Québec; 1997;
  21. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. Jama. 2005;293:2257–2264
  22. Roux C, Seeman E, Eastell R, et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004;20:433–439
  23. Vu MQ, Weintraub N, Rubenstein LZ. Falls in the nursing home: Are they preventable?. J Am Med Dir Assoc. 2004;5:401–406
  24. Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004;15:1003–1008
  25. Lips P, Ooms ME. Non-pharmacological interventions. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14:265–277
  26. Singh S, Sun H, Anis AH. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol. 2004;31:1607–1613
  27. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: A 3-year randomized controlled trial. Arch Intern Med. 2006;166:424–430
  28. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA. 2005;293:2257–2264
  29. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005;330:1003
  30. Grant AM, Avenell A, Campbell MK, et al. RECORD Trial Group Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): A randomised placebo-controlled trial. Lancet. 2005;365:1621–1628
  31. Jackson RD, LaCroix AZ, Gass M, et al. Women’s Health Initiative Investigators Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669–683
  32. Vecino C, Gratton M, Kremer R, et al. The seasonal variance in serum levels of vitamin D determines a compensatory response by parathyroid hormone: Study in an ambulatory elderly population in Quebec. Gerontology. 2006;52(1):33–39
  33. Greenspan SL, Schneider DL, McClung MR, et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities (A randomized, double-blind, placebo-controlled trial). Ann Intern Med. 2002;136:742–746
  34. Black DM, Cummings SR, Karpf DB, et al. Fracture Intervention Trial Research Group Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535–1541
  35. McClung MR, Geusens P, Miller PD, et al. Hip Intervention Program Study Group Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 2001;344:333–340
  36. Lyritis GP, Ioannidis GV, Karachalios T, et al. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: A prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain. 1999;15:284–289
  37. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Jama. 2002;288:321–333
  38. Hansdottir H, Franzson L, Prestwood K, et al. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. J Am Geriatr Soc. 2004;52:779–783
  39. Hodsman AB, Bauer DC, Dempster DW, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev. 2005;26:688–703

PII: S1525-8610(06)00617-7

doi: 10.1016/j.jamda.2006.12.010

JAMDA
Volume 8, Issue 3, Supplement 2 , Pages e67-e73 , March 2007

Article Tools